Craft
  • Home
  •  / Poseida Therapeutics
Poseida Therapeutics

Poseida Therapeutics

Total Funding

$336.5 M

Poseida Therapeutics Summary

Company summary

Overview
Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics. The Company's technology platforms have broad applicability and its long-term goal is to apply its proprietary gene editing technologies to a broad range of human diseases. The initial applications of Poseida’s technologies will be in gene therapy and CAR-T product candidates for liver disorders and cancer, respectively.
Type
Private
Status
Active
Founded
2015
HQ
San Diego, CA, US | view all locations
Website
https://poseida.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Mark J. Gergen

    Mark J. Gergen, Chief Executive Officer, Director

  • Kristin Martin

    Kristin Martin, Chief People and Administration Officer

  • Johanna Mylet

    Johanna Mylet, Chief Financial Officer

  • Brent Warner

    Brent Warner, President, Gene Therapy

    LocationsView all

    1 location detected

    • San Diego, CA HQ

      United States

      9390 Towne Centre Dr #200

    Footer menu